For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...
New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...
Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...
Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
Physicians received unexpected news recently when a small study published in JAMA Network Open found that ChatGPT-4 had outdone us at our own craft: diagnosis, what some have called the physician ...
her 15-item Myasthenia Gravis Quality of Life (MGQOL-15) and MG-associated Activities of Daily Living (MG-ADL) scores were 20 and 15, respectively, reflecting a considerable impact on her quality of ...
Mestinon (pyridostigmine) is a prescription drug used to treat myasthenia gravis. This drug can interact with other medications. For example, Mestinon can interact with corticosteroids and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results